00950 LEE'S PHARM
- 1.200
- +0.010+0.84%
LEE'S PHARM News
LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
LEE'S PHARM: Voluntary Announcement - Potential Acceptance Notice of Investigational New Drug Application of Recombinant Anfibatide Injection
LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
LEE'S PHARM: Notification Letter and Reply Form to Non-Registered Shareholders - Notice of Publication of Interim Report
LEE'S PHARM: Notification Letter and Reply Form to Registered Shareholders - Notice of Publication of Interim Report
LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
LEE'S PHARM: Interim Dividend for the Six Months Ended 30 June 2024
LEE'S PHARM: Voluntary Announcement - The First Patient in Hong Kong Receives AU409, a Novel Drug Product Manufactured by Zhaoke Guangzhou, in a Phase I Liver Cancer Clinical Trial
LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
LEE'S PHARM: List of Directors and their Roles and Functions
LEE'S PHARM: Appointment of Non-Executive Director
LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
LEE'S PHARM: Notification Letter to Non-registered Shareholders and Reply Form
LEE'S PHARM: Notification Letter to Registered Shareholders and Reply Form
LEE'S PHARM: Proxy Form
LEE'S PHARM: Environmental, Social and Governance Report 2023
LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Analysis
Price Target
No Data
No Data